THERAPEUTIC AGENT FOR HIGH-RISK MYELOFIBROSIS

The present invention relates to a novel therapeutic agent for high-risk myelofibrosis, said agent containing a compound represented by general formula [1] (in the formula, R1, R2, R3, R4, R5, and X are as defined in the description) or a pharmaceutically acceptable salt thereof as an active ingredi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	UNO Tomonori
Format:	Patent
Sprache:	eng ; fre ; jpn
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a novel therapeutic agent for high-risk myelofibrosis, said agent containing a compound represented by general formula [1] (in the formula, R1, R2, R3, R4, R5, and X are as defined in the description) or a pharmaceutically acceptable salt thereof as an active ingredient. La présente invention concerne un nouvel agent thérapeutique pour la myélofibrose à haut risque, ledit agent contenant un composé représenté par la formule générale [1] (dans la formule, R1, R2, R3, R4, R5 et X sont tels que définis dans la description) ou un sel pharmaceutiquement acceptable de celui-ci en tant que principe actif. 本発明は、一般式［１］：　［式中、Ｒ１、Ｒ２、Ｒ３、Ｒ４、Ｒ５、Ｘは、本明細書に記載の通りである］で表される化合物又はその医薬上許容される塩を有効成分として含有する新規な高リスク骨髄線維症の治療剤に関するものである。